Risk factors for late right ventricular systolic dysfunction in pediatric patients with repaired tetralogy of Fallot

Qiang Ji1, Yunqing Mei, Xisheng Wang

  • 1Department of Thoracic Cardiovascular Surgery of Tongji Hospital of Tongji University.

International Heart Journal
|December 16, 2014
PubMed

Insights

Low preoperative oxygen saturation, younger age at surgery, and transannular patch use are key risk factors for late right ventricular dysfunction in Tetralogy of Fallot (TOF) patients. Optimizing surgical timing and methods improves outcomes.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Echocardiography

Background:

  • Tetralogy of Fallot (TOF) repair is common in pediatric cardiology.
  • Late right ventricular systolic dysfunction is a significant concern after TOF correction.
  • Identifying risk factors is crucial for improving long-term outcomes.

Purpose of the Study:

  • To identify independent risk factors for late right ventricular systolic dysfunction following surgical correction of Tetralogy of Fallot (TOF).

Main Methods:

  • Retrospective observational study of 113 pediatric patients undergoing TOF correction.
  • Patients divided into groups based on right ventricular systolic function (assessed by TAPSV via pulsed wave-TDI).
  • Univariate and logistic regression analyses performed on clinical and surgical data.

Main Results:

  • Low preoperative arterial oxygen saturation (OR=1.66), age < 6 months at surgery (OR=3.45), and transannular patch use (OR=2.15) were identified as independent risk factors.
  • These factors were significantly associated with late right ventricular systolic dysfunction (P < 0.05).

Conclusions:

  • Low preoperative oxygen saturation is linked to poorer late right ventricular function post-TOF repair.
  • Appropriate surgical timing and outflow tract reconstruction techniques are vital for preserving right ventricular function in pediatric TOF survivors.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562